HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ohsang Kwon Selected Research

Urinary Tract Infections (Urinary Tract Infection)

5/2023Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ohsang Kwon Research Topics

Disease

24Alopecia (Baldness)
01/2024 - 07/2013
9Alopecia Areata
12/2023 - 11/2017
2Congenital Abnormalities (Deformity)
01/2024 - 01/2022
2Acne Vulgaris
05/2023 - 01/2022
2Breast Neoplasms (Breast Cancer)
01/2023 - 03/2015
2Atopic Dermatitis (Atopic Eczema)
01/2021 - 01/2020
2Inflammation (Inflammations)
01/2021 - 06/2014
2Neoplasms (Cancer)
03/2015 - 03/2014
1Kyphosis
01/2024
1Keratitis
12/2023
1Spinal Stenosis (Stenosis, Spinal)
08/2023
1Hematoma
08/2023
1Hemorrhage
08/2023
1Nasopharyngitis
05/2023
1Urinary Tract Infections (Urinary Tract Infection)
05/2023
1Headache (Headaches)
05/2023
1Respiratory Tract Infections (Respiratory Tract Infection)
05/2023
1Infections
05/2023
1COVID-19
05/2023
1Pain (Aches)
01/2023
1Intervertebral Disc Displacement (Herniated Disc)
01/2023
1Folliculitis (Sycosis)
04/2022
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
04/2022
1Hirsutism
04/2022
1Dermatitis
01/2020
1Drug-Related Side Effects and Adverse Reactions
01/2019
1Skin Diseases (Skin Disease)
06/2014
1Allergic Contact Dermatitis
11/2013

Drug/Important Bio-Agent (IBA)

5SaltsIBA
12/2023 - 01/2022
4tofacitinibIBA
09/2021 - 11/2017
3Minoxidil (Rogaine)FDA LinkGeneric
01/2024 - 01/2023
3baricitinibIBA
12/2023 - 01/2022
3Janus Kinase InhibitorsIBA
05/2023 - 08/2019
3CytokinesIBA
01/2022 - 06/2014
2Adrenal Cortex Hormones (Corticosteroids)IBA
12/2023 - 06/2023
2Janus KinasesIBA
05/2023 - 01/2022
2Creatine Kinase (Creatine Phosphokinase)IBA
05/2023 - 01/2022
2AndrogensIBA
04/2022 - 09/2013
2Proteins (Proteins, Gene)FDA Link
10/2021 - 01/2017
2Valproic Acid (Depakote)FDA LinkGeneric
04/2014 - 10/2013
1recombinant human bone morphogenetic protein-2IBA
01/2024
1tricalcium phosphateIBA
01/2024
1frovatriptan (Allegro)FDA Link
11/2023
1Phosphotransferases (Kinase)IBA
11/2023
1bone waxIBA
08/2023
1alfatradiolIBA
06/2023
1HDL CholesterolIBA
01/2022
1Complement System Proteins (Complement)IBA
01/2022
1Particulate MatterIBA
01/2022
1AdiponectinIBA
10/2021
1Peptides (Polypeptides)IBA
10/2021
1ruxolitinibIBA
09/2021
1Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2021
1SteroidsIBA
01/2021
1AmidesIBA
01/2020
1Dinitrochlorobenzene (DNCB)IBA
01/2020
1Dutasteride (Avodart)FDA Link
01/2019
1diphenylcyclopropenoneIBA
01/2019
1Sildenafil Citrate (Viagra)FDA Link
11/2018
1Cilostazol (Pletal)FDA LinkGeneric
07/2018
1Conditioned Culture MediaIBA
06/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
03/2015
1Epirubicin (Ellence)FDA LinkGeneric
03/2015
1Interleukin-13IBA
06/2014
1Coloring Agents (Dyes)IBA
11/2013
1CateninsIBA
10/2013
1Transforming Growth Factors (Transforming Growth Factor)IBA
09/2013
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2013
1SolutionsIBA
07/2013
1Epidermal Growth Factor (EGF)IBA
07/2013

Therapy/Procedure

5Drug Therapy (Chemotherapy)
01/2024 - 07/2013
5Therapeutics
12/2023 - 01/2019
1Decompression
08/2023
1Diskectomy (Discectomy)
01/2023
1Transplantation
03/2016